Recombinant Antibodies to the Ebola Virus Glycoprotein

Currently, there are no approved therapies for targeted prevention and treatment of Ebola hemorrhagic fever. In the present work, we describe the development of a eukaryotic expression system for the production of three full-length chimeric antibodies (IgG1-kappa isotypes) GPE118, GPE325, and GPE534...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Naturae
Autores principales: Panina, A. A., Dementieva, I. G., Aliev, T. K., Toporova, V. A., Balabashin, D. S., Bokov, M. N., Pozdnyakova, L. P., Shchemchukova, O. B., Dolgikh, D. A., Sveshnikov, P. G., Kirpichnikov, M. P.
Formato: Artigo
Lenguaje:Inglês
Publicado: A.I. Gordeyev 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762832/
https://ncbi.nlm.nih.gov/pubmed/29340221
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares